TY - JOUR T1 - An update on the use of inhaled therapy in COPD JF - Clinical Medicine JO - Clin Med SP - 387 LP - 390 DO - 10.7861/clinmedicine.18-5-387 VL - 18 IS - 5 AU - Oliver Price AU - Chandra Sarkar AU - Shruthi Konda Y1 - 2018/10/01 UR - http://www.rcpjournals.org/content/18/5/387.abstract N2 - Inhaled corticosteroids represent the mainstay of pharmacological treatment for reversible airways disease, and traditionally have had widespread use in non-reversible chronic obstructive pulmonary disease (COPD). However, use in this group may expose patients to an increased risk of pneumonia, without significant benefit to symptoms or exacerbation frequency. Here we provide a guide to the use of inhaled therapy in COPD for the general physician. ER -